We view the industrialisation agreement as increasing the likelihood of Advanced Oncotherapy (AVO) gaining a significant share of the Proton Beam Therapy market with its LIGHT system. This is because new potential customers will now have greater clarity on how the anticipated increase in production will be brought about after the first LIGHT system has been deployed in Harley Street. As such we believe that our DCF-derived 25p target price may prove conservative and, hence, reiterate our Buy
08 Feb 2016
Industrialisation agreement with Thales
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Industrialisation agreement with Thales
Advanced Oncotherapy Plc (AVO:LON) | 1.9 0 0.0% | Mkt Cap: 10.4m
- Published:
08 Feb 2016 -
Author:
Robert Sanders -
Pages:
2
We view the industrialisation agreement as increasing the likelihood of Advanced Oncotherapy (AVO) gaining a significant share of the Proton Beam Therapy market with its LIGHT system. This is because new potential customers will now have greater clarity on how the anticipated increase in production will be brought about after the first LIGHT system has been deployed in Harley Street. As such we believe that our DCF-derived 25p target price may prove conservative and, hence, reiterate our Buy